509151-97-7 Usage
Description
Ethanol, 2-[(2-fluoro-4-nitrophenyl)amino](9CI) is an organic compound with the molecular formula C8H8FN2O3. It is a chemical reagent known for its role in the synthesis of various pharmaceutical compounds, particularly oxazolidinone antibiotics and other anti-bacterial agents. Ethanol, 2-[(2-fluoro-4-nitrophenyl)amino](9CI) is characterized by its fluoro and nitro functional groups, which contribute to its reactivity and potential applications in the chemical and pharmaceutical industries.
Uses
Used in Pharmaceutical Industry:
Ethanol, 2-[(2-fluoro-4-nitrophenyl)amino](9CI) is used as a chemical reagent for the synthesis of oxazolidinone compounds. These compounds are known for their antibiotic properties and are effective against a wide range of bacterial infections. The unique structure of this reagent allows for the creation of new and potent antibiotics, which can be crucial in the ongoing battle against antibiotic resistance.
Additionally, this compound can be used in the development of other anti-bacterial agents, expanding its applications beyond just antibiotics. The versatility of Ethanol, 2-[(2-fluoro-4-nitrophenyl)amino](9CI) makes it a valuable asset in the pharmaceutical industry, as it can contribute to the discovery and production of new drugs to combat bacterial infections.
Used in Chemical Research:
In the field of chemical research, Ethanol, 2-[(2-fluoro-4-nitrophenyl)amino](9CI) can be employed as a starting material or intermediate in the synthesis of various organic compounds. Its unique structure and functional groups make it an attractive candidate for further modification and exploration, potentially leading to the discovery of new compounds with novel properties and applications.
Researchers can utilize this compound to investigate the effects of fluoro and nitro substitutions on the reactivity and stability of organic molecules, as well as to study the mechanisms of various chemical reactions. This can contribute to a deeper understanding of organic chemistry and the development of new synthetic strategies and methodologies.
Check Digit Verification of cas no
The CAS Registry Mumber 509151-97-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,9,1,5 and 1 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 509151-97:
(8*5)+(7*0)+(6*9)+(5*1)+(4*5)+(3*1)+(2*9)+(1*7)=147
147 % 10 = 7
So 509151-97-7 is a valid CAS Registry Number.
509151-97-7Relevant articles and documents
METHOD FOR PREPARING (R)-3-(3-FLUORO-4-(1-METHYL-5,6-DIHYDRO-1,2,4-TRIAZIN-4(1H)-YL)PHENYL)-5-(SUBSTITUTED METHYL)OXAZOLIDIN-2-ONE DERIVATIVES
-
Page/Page column 6, (2013/02/28)
Provided are a method for preparing (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives, which are oxazolidinone antibiotic compounds having a cyclic amidrazone group, represented by Chemical Formula 1, and intermediates thereof, and uses 3,4-difluoro-4-nitrobenzen as a starting material. According to the preparation method of the present invention, (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives, which are useful as oxazolidinone antibiotics, can be prepared in high purity and high yield in a simpler manner than conventional methods.
NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES
-
Page/Page column 113, (2012/11/14)
The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
Observation of O→N type smiles rearrangement in certain alkyl aryl nitro compounds
Selvakumar, Natesan,Srinivas, Deekonda,Azhagan, Azagarsamy Malar
, p. 2421 - 2425 (2007/10/03)
Smiles rearrangements on some alkyl aryl nitro compounds having NH2 group as the nucleophile and oxygen as the leaving group are reported.
